MOLECULAR MECHANISM OF MINERALOCORTICOID RECEPTOR ACTION
盐皮质激素受体作用的分子机制
基本信息
- 批准号:6628558
- 负责人:
- 金额:$ 27.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-01 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:Xenopus aldosterone chromatin confocal scanning microscopy corticosteroid receptors genetic transcription green fluorescent proteins hormone regulation /control mechanism immunocytochemistry intermolecular interaction ion transport laboratory mouse laboratory rabbit nuclear matrix nuclear receptors protein binding protein structure receptor expression renal tubule site directed mutagenesis sodium ion transfection /expression vector yeast two hybrid system
项目摘要
The long-term objective of these studies is the understanding of the molecular mechanisms through which aldosterone stimulates Na transport and thereby regulates blood pressure. This project focuses on the initial nuclear events initiated by the hormone-liganded mineralocorticoid receptor (MR), in cells of its major target, the cortical collecting duct (CCD). The foundation of these studies is our recent observation that aldosterone induces MR clustering in the nucleus, whereas MR antagonists dissociate such clusters. Our studies also indicate that MR clusters are associated with the nuclear matrix but not with pallindromic hormone response elements. Our central hypothesis is that clustering of MRs is a critical step in the mechanism of action of aldosterone, and that foci of high MR density are also enriched in proteins involved in chromatin remodeling and in basal transcription factors. Consequently, the main goal of this project is to identify proteins interacting with the MR, that are responsible for its clustering and/or play a critical role in the major biological action of aldosterone. In aim 1, we will identify the nuclear subcompartment where the agonist-liganded MR clusters reside, and will determine which residues of the MR are involved in receptor clustering. These studies will employ side-directed mutagenesis of MR-green fluorescent protein chimeras, immunocytochemistry and confocal microscopy. Under Aim 2, we will identify and characterize proteins expressed in the CCD that directly interact with the agonist-liganded MR, using transcription- and signal transduction-based yeast two-hybrid screens. We will identify regions of interaction of MR with MR-interacting proteins (MRIPs), generate antibodies against MRIPs, and construct expression vectors capable of disrupting MR/MRIP interactions in vivo. In Aim 3, we will determine the role of MRIPs in MR clustering and in the biological responses initiated by aldosterone. We will determine the effects of manipulating the expression of MRIPs and disruption of their interaction with the MR, on aldosterone-induced receptor clustering, transcriptional regulation of an endogenous aldosterone target gene and on changes in Na transport in CCD cells. Identification of the molecular events involved in MR action should not only yield new insights into the mechanism of transcriptional regulation by aldosterone, but could also lead to the identification of genetic defects resulting in derangement of Na homeostasis, leading to hypertension (as in Liddle syndrome) or salt wasting (as in pseudohypoaldosteronism).
这些研究的长期目标是对醛固酮刺激NA转运并因此调节血压的分子机制的理解。 该项目着重于其主要靶标(CCD)细胞中激素辅助矿物皮质激素受体(MR)引发的初始核事件。 这些研究的基础是我们最近的观察结果,即醛固酮在细胞核中诱导MR聚类,而MR拮抗剂分离了此类簇。 我们的研究还表明,簇MR与核基质有关,但与全核激素反应元件无关。我们的中心假设是,MRS的聚类是醛固酮作用机理的关键步骤,高MR密度的焦点也富含参与染色质重塑和基础转录因子的蛋白质。因此,该项目的主要目标是识别与MR相互作用的蛋白质,这些蛋白质是导致其聚类和/或在醛固酮的主要生物学作用中起关键作用的蛋白质。 在AIM 1中,我们将确定由激动剂配合的MR簇驻留的核季节,并确定MR的哪些残基参与受体聚类。 这些研究将采用MR绿色荧光蛋白嵌合体,免疫细胞化学和共聚焦显微镜的侧向指导诱变。 在AIM 2下,我们将使用基于转录和信号转导的基于转录的酵母两杂化筛选在CCD中表达的蛋白质并表征直接与激动剂配合的MR相互作用的蛋白质。 我们将确定MR与MR相互作用蛋白(MRIP)相互作用的区域,对MRIP产生抗体,并构建能够破坏体内MR/MRIP相互作用的表达向量。 在AIM 3中,我们将确定MRIP在MR聚类中的作用以及醛固酮发起的生物学反应。 我们将确定操纵MRIP表达的影响和与MR的相互作用的破坏,对醛固酮诱导的受体聚类,内源性醛固酮靶基因的转录调控以及CCD细胞中NA转运的变化。鉴定MR动作中涉及的分子事件不仅应产生对醛固酮转录调控的机制的新见解,而且还可能导致遗传缺陷鉴定导致NA稳态危险,从而导致高血压(如在Liddle综合征中)或盐分浪费(如Pseudohypohypoaldasterpoaltasterpoartasterpoaltastermastermasterism)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEZA FEJES-TOTH其他文献
GEZA FEJES-TOTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEZA FEJES-TOTH', 18)}}的其他基金
The Role of Cardiovascular Mineralocorticoid Receptors in Health and Disease
心血管盐皮质激素受体在健康和疾病中的作用
- 批准号:
7575668 - 财政年份:2008
- 资助金额:
$ 27.42万 - 项目类别:
The Role of Cardiovascular Mineralocorticoid Receptors in Health and Disease
心血管盐皮质激素受体在健康和疾病中的作用
- 批准号:
7780010 - 财政年份:2008
- 资助金额:
$ 27.42万 - 项目类别:
The Role of Cardiovascular Mineralocorticoid Receptors in Health and Disease
心血管盐皮质激素受体在健康和疾病中的作用
- 批准号:
7369910 - 财政年份:2008
- 资助金额:
$ 27.42万 - 项目类别:
MOLECULAR MECHANISM OF MINERALOCORTICOID RECEPTOR ACTION
盐皮质激素受体作用的分子机制
- 批准号:
6350734 - 财政年份:2000
- 资助金额:
$ 27.42万 - 项目类别:
MOLECULAR MECHANISM OF MINERALOCORTICOID RECEPTOR ACTION
盐皮质激素受体作用的分子机制
- 批准号:
6498156 - 财政年份:2000
- 资助金额:
$ 27.42万 - 项目类别:
MOLECULAR MECHANISM OF MINERALOCORTICOID RECEPTOR ACTION
盐皮质激素受体作用的分子机制
- 批准号:
6044901 - 财政年份:2000
- 资助金额:
$ 27.42万 - 项目类别:
相似国自然基金
醛固酮诱导巨噬细胞原位增殖参与肾脏纤维化的机制及益气解毒化瘀中药的拮抗作用
- 批准号:82305121
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
醛固酮瘤丙酸代谢异常通过MMA-肥大细胞-5-羟色胺-PCCA环路促进醛固酮合成的机制研究
- 批准号:82300887
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卤代苯醌对肾素-血管紧张素-醛固酮系统的内分泌干扰作用及肾毒性机制
- 批准号:22206151
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
GNA11/GNAQ和CTNNB1双重突变导致醛固酮瘤和继发性高血压的发病机制探索
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于血钙激活CaSR调控醛固酮合成探讨原发性醛固酮增多症的发病机制
- 批准号:82200880
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Aldosterone/mineralocorticoid receptor responses to biologic sex and salt intake: Role of Lysine Specific Demethylase 1 (LSD1)
醛固酮/盐皮质激素受体对生物性别和盐摄入量的反应:赖氨酸特异性脱甲基酶 1 (LSD1) 的作用
- 批准号:
10930190 - 财政年份:2023
- 资助金额:
$ 27.42万 - 项目类别:
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis
靶向平滑肌细胞 BMAL1 作为抗再狭窄的新治疗策略
- 批准号:
10561398 - 财政年份:2023
- 资助金额:
$ 27.42万 - 项目类别:
The sexually dimorphic role of smooth muscle cell estrogen receptor alpha in vascular aging
平滑肌细胞雌激素受体α的性二态性在血管衰老中的作用
- 批准号:
10641912 - 财政年份:2022
- 资助金额:
$ 27.42万 - 项目类别:
Epigenetic regulation of aldosterone and salt sensitivity in hypertension
高血压醛固酮和盐敏感性的表观遗传调控
- 批准号:
9415442 - 财政年份:2016
- 资助金额:
$ 27.42万 - 项目类别:
Epigenetic regulation of aldosterone and salt sensitivity in hypertension
高血压醛固酮和盐敏感性的表观遗传调控
- 批准号:
9211373 - 财政年份:2016
- 资助金额:
$ 27.42万 - 项目类别: